Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
Martin Reck, Tudor–Eliade Ciuleanu, Michael Schenker, Stephanie Bordenave, Manuel Cobo, Óscar Juan and 16 more
- Rank
- 4 of 1,155
- Percentile
- top 0.4%
- Where
- European Journal of Cancer, 2024
- Citations
- 88
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.